| Intravenous Fosfomycin Pharmacokinetics Study (NCT03910673) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-06-27 |
| Bioequivalence Study of Feniramidol HCl 400 mg Film Tablet (Pharmactive, Turkey) Under Fed Conditions (NCT04639869) | Humanis Saglık Anonim Sirketi | 2019-06-26 |
| A Study to Describe the Safety Profile and Compare the Immune Response of 4 Different Formulations of an Investigational Tdap Vaccine When Compared to Licensed Tdap Vaccine in Young Adults in Canada (NCT03958799) | Sanofi Pasteur, a Sanofi Company | 2019-06-26 |
| A Study of mRNA-5671/V941 as Monotherapy and in Combination With Pembrolizumab (V941-001) (NCT03948763) | Merck Sharp & Dohme LLC | 2019-06-26 |
| Phase I/II Study of Rapcabtagene Autoleucel in CLL, 3L+ DLBCL, r/r ALL and 1L HR LBCL (NCT03960840) | Novartis Pharmaceuticals | 2019-06-26 |
| A Study of EDP-514 in Healthy Subjects (Part 1) and Patients With Chronic Hepatitis B Virus Infection (Part 2) (NCT04008004) | Enanta Pharmaceuticals, Inc | 2019-06-26 |
| A Phase 1 Drug-Drug Interaction Study Between Brigatinib and the CYP3A Substrate, Midazolam, in Participants With ALK-Positive or ROS1-Positive Solid Tumors (NCT03420742) | Takeda | 2019-06-26 |
| Comparing of the Pharmacokinetic, Pharmacodynamic, Safety and Immunogenicity of MW032 and Xgeva® in Healthy Adults (NCT04798326) | Mabwell (Shanghai) Bioscience Co., Ltd. | 2019-06-25 |
| A Study of Telaglenastat (CB-839) in Combination With Palbociclib in Patients With Solid Tumors (NCT03965845) | Calithera Biosciences, Inc | 2019-06-25 |
| PriCoTTF Study: TTFields Before and During Radiotherapy for Newly Diagnosed Glioblastoma (NCT07120620) | Sied Kebir | 2019-06-25 |
| Bioequivalence of Two Formulations of Levothyroxine Sodium 200 Micrograms (mcg) Under Tablet Form (NCT04037748) | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | 2019-06-25 |
| Study of FCN-437c in Patients With Advanced Solid Tumors (NCT03951116) | Fochon Pharmaceuticals, Ltd. | 2019-06-25 |
| A Study to Evaluate Safety, Engraftment, and Efficacy of VC-01 in Subjects With T1 Diabetes Mellitus (NCT04678557) | ViaCyte | 2019-06-25 |
| Clinical Study on the Treatment of Recurrent Glioblastoma With Anlotinib (NCT04004975) | Shandong Cancer Hospital and Institute | 2019-06-25 |
| Phase 1 Trial of the LSD1 Inhibitor SP-2577 (Seclidemstat) in Patients With Advanced Solid Tumors (NCT03895684) | Salarius Pharmaceuticals, LLC | 2019-06-25 |
| Fed Bioequivalence Study of 2 Metformin 500 mg Prolongued Release Tablets in 28 Healthy Male and Female Volunteers (NCT05124717) | Joint Stock Company "Farmak" | 2019-06-25 |
| A Mass Balance and Pharmacokinetics Study of 14C-Labeled Poziotinib in Cancer Patients Suitable for Treatment With Poziotinib (NCT03804515) | Spectrum Pharmaceuticals, Inc | 2019-06-25 |
| A Study Designed to Evaluate the Pharmacokinetic Profile of Abiraterone (NCT04295161) | Zentiva, k.s. | 2019-06-25 |
| Safety and Preliminary Efficacy Study of MRG001 in Patients With Non-Hodgkin Lymphoma (NHL) (NCT05155839) | Shanghai Miracogen Inc. | 2019-06-25 |
| A Study Assessing AR-13503 Implant in Subjects With nAMD or DME (NCT03835884) | Aerie Pharmaceuticals | 2019-06-24 |
| HDM201 in Combination With MBG453 or Venetoclax in Patients With Acute Myeloid Leukemia (AML) or High-risk Myelodysplastic Syndrome (MDS) (NCT03940352) | Novartis Pharmaceuticals | 2019-06-24 |
| Treating Acute Pancreatitis With Dabigatran, a Pilot Study (NCT03807856) | Mayo Clinic | 2019-06-24 |
| A Study to Evaluate Safety and Therapeutic Activity of RO6874281 in Combination with Pembrolizumab, in Participants with Advanced or Metastatic Melanoma (NCT03875079) | Hoffmann-La Roche | 2019-06-24 |
| A Single and Multiple Ascending Dose Study to Evaluate the Safety and Pharmacokinetics of PU-AD in Healthy Subjects (NCT03935568) | Samus Therapeutics, Inc. | 2019-06-24 |
| Relative Bioavailability of MN-166 (Ibudilast) in Extended Release Tablet vs. Intermediate-release Capsule in Healthy Volunteers (NCT04054206) | MediciNova | 2019-06-24 |
| A Study of a Single Subcutaneous Dose of JNJ-26366821 in Healthy Participants (NCT03990519) | Janssen Research & Development, LLC | 2019-06-24 |
| Study of TQB2450 Combined With Anlotinib in Subjects With Advanced Cholangiocarcinoma (NCT03996408) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2019-06-24 |
| FIGHT-RP 1 Extension Study (NCT03999021) | Johns Hopkins University | 2019-06-24 |
| ABI-M201 in Adult Subjects With Mildly-to-Moderately Active Ulcerative Colitis (NCT03923478) | Assembly Biosciences | 2019-06-24 |
| Tumor Associated Antigen Specific T Cells (TAA-T) With PD1 Inhibitor for Lymphoma (NCT03843294) | Catherine Bollard | 2019-06-24 |
| A Single Ascending Dose Study of AV-006 in Healthy Subjects (NCT03931876) | Arixa Pharmaceuticals | 2019-06-24 |
| Onvansertib in Combination With FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colorectal Cancer Patients With a KRAS Mutation (NCT03829410) | Cardiff Oncology | 2019-06-24 |
| Tolerability, Safety and Pharmacokinetics of a Topical AB001 Patch in Healthy Subjects (NCT03997734) | Frontier Biotechnologies Inc. | 2019-06-24 |
| Safety and Tolerance Study of Recombinant Human Albumin Injection in Healthy Subjects. (NCT04641364) | The First Hospital of Jilin University | 2019-06-24 |
| A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Upadacitinib in Pediatric Subjects With Polyarticular Course Juvenile Idiopathic Arthritis (NCT03725007) | AbbVie | 2019-06-24 |
| A Study to Compare Nivolumab Drug Product Process D to Nivolumab Drug Product Process C in Participants With Stage IIIa/b/c/d or Stage IV Melanoma After Complete Resection (NCT03980314) | Bristol-Myers Squibb | 2019-06-24 |
| A Study of TNB-383B in Participants With Relapsed or Refractory Multiple Myeloma (NCT03933735) | AbbVie | 2019-06-24 |
| Rekovelle PK Trial in Chinese Women (NCT04150861) | Ferring Pharmaceuticals | 2019-06-23 |
| Study to Determine the Excretion and Metabolism of 14C-ETX2514 Administered Intravenously in Healthy Male Subjects (NCT04018950) | Entasis Therapeutics | 2019-06-21 |
| RUCONEST® as a Therapeutic Strategy to Reduce the Incidence of Delayed Graft Function (NCT03791476) | University of Wisconsin, Madison | 2019-06-21 |
| Effect of Berberine for Endothelial Function and Intestinal Microflora in Patients With Coronary Artery Disease (NCT04434365) | Peking Union Medical College Hospital | 2019-06-21 |
| Regorafenib and Pembrolizumab in Treating Participants With Advanced or Metastatic Colorectal Cancer (NCT03657641) | University of Southern California | 2019-06-21 |
| A Phase I Clinical Trial of BAT1306 and BAT8001 Injection in Patients With Solid Tumor (NCT04151329) | Bio-Thera Solutions | 2019-06-21 |
| A Drug Interaction Study of LY3154207 in Healthy Participants (NCT03942029) | Eli Lilly and Company | 2019-06-21 |
| Venetoclax and Selinexor in Treating Patients with Relapsed or Refractory High Risk Hematologic Malignancies (NCT03955783) | Sanjay Mohan | 2019-06-21 |
| Ixazomib and Dexamethasone With or Without Venetoclax in Treating Patients With Non-t(11;14) Relapsed or Refractory Multiple Myeloma (NCT03856112) | National Cancer Institute (NCI) | 2019-06-21 |
| Platform Study for Prostate Researching Translational Endpoints Correlated to Response to Inform Use of Novel Combinations (NCT03835533) | Parker Institute for Cancer Immunotherapy | 2019-06-21 |
| Opioid and Cannabinoid Interactions (NCT03705559) | Shanna Babalonis, PhD | 2019-06-21 |
| ZILRETTA™ for Treatment of Idiopathic Adhesive Capsulitis (NCT04831255) | University of Virginia | 2019-06-21 |
| A Study of LY3526318 in Healthy Participants (NCT03977974) | Eli Lilly and Company | 2019-06-21 |
| Clinical Study to Assess Safety, PK and PD Parameters of CDR132L (NCT04045405) | Cardior Pharmaceuticals GmbH | 2019-06-21 |
| To Compare the Pharmacokinetics and Safety of the Auto-injector and Pre-filled Syringe of CT-P17 (NCT04295356) | Celltrion | 2019-06-21 |
| Effect of Rifampin and Efavirenz on the Pharmacokinetics of Fedratinib in Healthy Adult Subjects (NCT03983239) | Celgene | 2019-06-21 |
| PhaseⅠStudy of the HS-10241 in Patients With Advanced Solid Tumors (NCT04477057) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2019-06-21 |
| Safety and Pharmacokinetics of AT-007 in Healthy Subjects and in Adult Subjects With Classic Galactosemia (NCT04117711) | Applied Therapeutics, Inc. | 2019-06-21 |
| Sonodynamic Therapy in the Treatment of Perivascular Adipose Tissue on Patients With PAD and Claudication (NCT03967730) | First Affiliated Hospital of Harbin Medical University | 2019-06-20 |
| Safety and Immunogenicity of a Single Dose of the Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV ΔNS2/Δ1313/I1314L, RSV 6120/ΔNS2/1030s, RSV 276 or Placebo, Delivered as Nose Drops to RSV-Seronegative Children 6 to 24 Months of Age (NCT03916185) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-06-20 |
| A Study Evaluating Safety and Therapeutic Activity of THOR-707 in Adult Subjects With Advanced or Metastatic Solid Tumors (THOR-707-101) (NCT04009681) | Synthorx, Inc, a Sanofi company | 2019-06-20 |
| Study to Evaluate Hepatic Artery Injection of Autologous Human Bone Marrow-Derived MSCs in Patients With Alcoholic LC (NCT03838250) | Pharmicell Co., Ltd. | 2019-06-20 |
| Comparison of the Effectiveness of Povidone-Iodine Alone to Povidone-Iodine-Tetracycline Combination (NCT04039126) | University College Hospital, Ibadan | 2019-06-20 |
| Study to Evaluate the Effect of Multiple Doses of Itraconazole and Rifampin on the Single-Dose Pharmacokinetics of Mitapivat Sulfate (AG-348) in Healthy Adult Participants (NCT03991312) | Agios Pharmaceuticals, Inc. | 2019-06-20 |
| A Study in Patients With Different Types of Advanced Cancer (Solid Tumors) to Test Different Doses of BI 907828 (Brigimadlin) in Combination With BI 754091 (Ezabenlimab) and BI 754111 or BI 907828 (Brigimadlin) in Combination With BI 754091 (Ezabenlimab) (NCT03964233) | Boehringer Ingelheim | 2019-06-20 |
| Study of TQB2450 Combined With Anlotinib in Patients With Advanced Solid Tumors (NCT03897283) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2019-06-20 |
| TACE Combined With PD-1 Knockout Engineered T Cell in Advanced Hepatocellular Carcinoma. (NCT04417764) | Central South University | 2019-06-20 |
| Study to Investigate the Effects of Single Intravenous Doses of Difelikefalin (CR845) on the QTc Interval in Healthy Subjects (NCT04019574) | Cara Therapeutics, Inc. | 2019-06-20 |
| Pevonedistat and Belinostat in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome (NCT03772925) | National Cancer Institute (NCI) | 2019-06-20 |
| A Study of Itolizumab (EQ001) to Evaluate the Safety, Tolerability, PK, PD, and Clinical Activity in Uncontrolled Asthma (NCT04007198) | Biocon Limited | 2019-06-20 |
| Safety, Tolerability and Potential Efficacy of AVT001 in Patients With Type 1 Diabetes (NCT03895996) | Avotres Inc. | 2019-06-20 |
| The Safety, Tolerability and Efficacy of Multiple Subcutaneous Injections of SHR-1209 in Subjects With Hyperlipidemia (NCT03944109) | Jiangsu HengRui Medicine Co., Ltd. | 2019-06-20 |
| Geriatric Recovery Using Inpatient and Post-hospitalization Supplementation (NCT03904615) | The University of Texas Medical Branch, Galveston | 2019-06-19 |
| A Study of HS-10342 in Patients With Advanced Solid Tumor (NCT04060511) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2019-06-19 |
| A Study to Evaluate the Pharmacokinetics of Tezepelumab After Being Delivered by an Accessorized Pre Filled Syringe or Autoinjector Compared With Vial and Syringe in Healthy Adult Subjects (NCT03989544) | AstraZeneca | 2019-06-19 |
| Low Dose IL2 Immunotherapy in AD (NCT05821153) | The Methodist Hospital Research Institute | 2019-06-19 |
| A Study of ASP2215 (Gilteritinib) Combined With Atezolizumab in Patients With Relapsed or Treatment Refractory FMS-like Tyrosine Kinase (FLT3) Mutated Acute Myeloid Leukemia (AML) (NCT03730012) | Astellas Pharma Global Development, Inc. | 2019-06-19 |
| A Study of MK-0482 as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-0482-001) (NCT03918278) | Merck Sharp & Dohme LLC | 2019-06-19 |
| Study of NaQuinate in Healthy Volunteers (NCT04036617) | Haoma Medica Limited | 2019-06-18 |
| Single-ascending Dose Phase 1 Clinical Trial to Evaluate the Safety and PK of DA-5207 TDS in Healthy Adults (NCT04013477) | Dong-A ST Co., Ltd. | 2019-06-18 |
| An Ascending Dose Study of BMS-986259 to Study Safety in Healthy Participants (NCT04008992) | Bristol-Myers Squibb | 2019-06-18 |
| EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults (NCT03618381) | Seattle Children's Hospital | 2019-06-18 |
| KN026 in Patients With HER2 Expressing Breast Cancer and Gastric Cancer (NCT03847168) | Jiangsu Alphamab Biopharmaceuticals Co., Ltd | 2019-06-18 |
| Safety, Tolerability, and Pharmacokinetics of Multiple Doses of Intravenous Nafithromycin (NCT03981887) | Wockhardt | 2019-06-18 |
| Cysteamine for Asthma (NCT03883984) | Children's Hospital Medical Center, Cincinnati | 2019-06-18 |
| Comparision of Pharmacokinetics(PK) and Pharmacodynamics(PD) of Biocon Insulin R and Humulin® R (NCT04022317) | Biocon Limited | 2019-06-18 |
| A Study to Test How Well Healthy Men Tolerate Different Doses of BI 706321 (NCT03971695) | Boehringer Ingelheim | 2019-06-18 |
| A Drug-drug Interaction Study With Risdiplam Multiple Dose and Midazolam in Healthy Participants (NCT03988907) | Hoffmann-La Roche | 2019-06-18 |
| Trabectedin and Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Resistant or Intolerant to a BTK Inhibitor (NCT03884972) | M.D. Anderson Cancer Center | 2019-06-18 |
| Dual bNAb Treatment in Children (NCT03707977) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-06-17 |
| Phase I Study of HL-085 in Patients With Advanced Solid Tumors (NCT03976050) | Shanghai Kechow Pharma, Inc. | 2019-06-17 |
| Multi-center, Open-label, Phase 1b Clinical Trial to Evaluate the Safety, Tolerability, and Exploratory Efficacy of TEW-7197 in Combination With FOLFOX in Patients With Metastatic Pancreatic Ductal Adenocarcinoma Who Have Failed First-Line Gemcitabine and Nab-Paclitaxel (NCT03666832) | Joon Oh Park | 2019-06-17 |
| A Safety, Pharmacokinetic and Clinical Activity Study of NUC-7738 in Patients With Advanced Solid Tumours and Lymphoma (NCT03829254) | NuCana plc | 2019-06-17 |
| Preoperative Nerve Block for Rhinoplasty/Septoplasty (NCT03780478) | University of Southern California | 2019-06-17 |
| VAC 072-An Efficacy Study of R21/MM in Different Dose Schedules (NCT03970993) | University of Oxford | 2019-06-17 |
| Study to Evaluate Rate of Nausea in Healthy Premenopausal Female Subjects Treated With Single Dose of Bremelanotide Alone or With Zofran (NCT03973047) | AMAG Pharmaceuticals, Inc. | 2019-06-17 |
| Safety, Tolerability and Pharmacokinetics of ERX-963 in Adults With Myotonic Dystrophy Type 1 (NCT03959189) | Expansion Therapeutics, Inc. | 2019-06-17 |
| Nivolumab and Multi-fraction Stereotactic Radiosurgery With or Without Ipilimumab in Treating Patients With Recurrent Grade II-III Meningioma (NCT03604978) | National Cancer Institute (NCI) | 2019-06-17 |
| Evaluation of the Safety, Tolerability and Pharmacokinetics (PK) of GSK3732394 First-Time-in-Human (FTIH) Study (NCT03984812) | ViiV Healthcare | 2019-06-17 |
| Survivin Long Peptide Vaccine in Treating Patients With Metastatic Neuroendocrine Tumors (NCT03879694) | Roswell Park Cancer Institute | 2019-06-17 |
| Study to Evaluate Pharmacokinetics, Safety and Tolerability of Dolutegravir and Rilpivirine (JULUCA™) 50 Milligram (mg)/25 mg Tablets in Healthy Subjects of Japanese Descent (NCT03984838) | ViiV Healthcare | 2019-06-17 |
| Pharmacokinetic, Safety and Immunogenicity Study of CMAB809 and Herceptin in Healthy Volunteers (NCT04049409) | Taizhou Mabtech Pharmaceutical Co.,Ltd | 2019-06-17 |
| A Study of LP002 for the Treatment of Patients With Malignant Digestive System Neoplasms (NCT04755543) | Taizhou HoudeAoke Biomedical Co., Ltd. | 2019-06-17 |